Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Sanofi »

AgomAb Therapeutics NV shares owned by Sanofi

Quarter-by-quarter ownership of AgomAb Therapeutics NV shares owned by Sanofi from 13F filings

Historical chart of Sanofi investment in AgomAb Therapeutics NV

Tip: Access up to 7 years of quarterly data

All positions including AgomAb Therapeutics NV held by Sanofi consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in AgomAb Therapeutics NV by Sanofi

Quarter filed	Position value	Share count	Share price at filing
2026-03-31	$29M	2.8M	10.49

More positions owned by Sanofi

Meiragtx Holdings (MGTX)

Inhibrx Biosciences (INBX)

Novavax Com New (NVAX)

Anaptysbio Inc Common (ANAB)

Agomab Therapeutics NV Sponsored Ads

Maplight Therapeutics (MPLT)

Immuneering Corp Class A Com (IMRX)

Eledon Pharmaceuticals (ELDN)

View all positions for Sanofi

Top funds holding AgomAb Therapeutics NV

Federated Investors

Andera Partners

Standard Life Aberdeen

Seven Grand Managers

View all funds holding AgomAb Therapeutics NV

© 2026 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z